Ivermectin And Pyrantel Pamoate

Verify with FDA CVM →

30 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
30
Total Reports
3
Deaths Reported
1000.0%
Death Rate

Active Ingredients

Ivermectin And Pyrantel Pamoate

Administration Routes

UnknownOral

Species Affected

Dog 30

Most Affected Breeds

Shepherd Dog - German 4
Retriever - Labrador 3
Mountain Dog - Bernese 2
Beagle 2
Retriever - Chesapeake Bay 2
Rottweiler 2
Retriever - Golden 2
Terrier - Yorkshire 1
Collie - Smooth-haired 1
Siberian Husky 1

Most Reported Reactions

Diarrhoea 8
Vomiting 8
Lethargy (see also Central nervous system depression in 'Neurological') 6
Elevated alanine aminotransferase (ALT) 6
Weight loss 4
Other abnormal test result NOS 4
Lameness 4
Lethargy (see also Central nervous system depression in Neurological) 4
Erythema (for urticaria see Immune SOC) 3
Papule 3
Thrombocytopenia 3
Neutrophilia 3

Outcome Breakdown

Outcome Unknown
13 (43.3%)
Recovered/Normal
7 (23.3%)
Ongoing
7 (23.3%)
Died
2 (6.7%)
Euthanized
1 (3.3%)

Data Summary

Metric Value
Total adverse event reports 30
Reports involving death 3
Case-fatality rate (reported events) 1000.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin And Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 30 adverse event reports referencing Ivermectin And Pyrantel Pamoate, including 3 reports in which the animal died — a 1000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin And Pyrantel Pamoate. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin And Pyrantel Pamoate reports are Dog (30 reports), with Dog accounting for the largest share. Within those species, Shepherd Dog - German (4), Retriever - Labrador (3), Mountain Dog - Bernese (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin And Pyrantel Pamoate are Diarrhoea (8), Vomiting (8), Lethargy (see also Central nervous system depression in 'Neurological') (6), Elevated alanine aminotransferase (ALT) (6). Of the 30 reports with a coded outcome, Outcome Unknown is the leading category at 43.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin And Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial